Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors

clinical trial

Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT03950609

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2021-05-07
P1050medical conditionmultiple endocrine neoplasiaQ1553018
multiple endocrine neoplasia type 1Q3347154
P2899minimum age18
P1132number of participants32
P4844research interventionsirolimusQ32089
P580start time2019-06-30
P8363study typeinterventional studyQ78089383
P1476titleA Phase II Study of Lenvatinib in Combination With Everolimus in Patients With Advanced Carcinoid Tumors

Search more.